References
- Astrup T., Galsmar I., Volkert M. Polysaccharide Sulphuric Acids as Anticoagulants. Acta physiol. Scandinav. 1944; 8: 215
- Astrup T., Piper J. Cellulose Sulphuric Acids as Anticoagulants. Acta physiol. Scandinav. 1945a; 9: 351
- Astrup T., Piper J. Om de syntetiske, koagulationshemmende Polysaccharidsvovlsyreesteres Egenskaber, Virkning i Organismen og mulige Betydning for Emboliproblemet. Nord. med. 1945b; 28: 3405
- Astrup T., Piper J. Interaction Between Fibrinogen and Polysaccharide Polysulphuric Acids. Acta physiol. Scandinav. 1946; 11: 211
- Balazs E. A., Högberg B., Laurent T. C. The Biological Activity of Hyaluron Sulphuric Acid. Acta physiol. Scandinav. 1951; 23: 168
- Baronofsky I. D., Quick A. J. Heparin and the Agglutination of Platelets in Vitro. Proc. Soc. Exper. & Biol. Med. 1943; 53: 173
- Barsøe O. C, Selsø S. On the Antiocoagulant Action of Synthetic Polysaccharide Polysulphuric Acids. Acta Pharmacol, et toxicol. 1946; 2: 367
- Bergström S. Über die Wirkungsgruppe des Heparins. Naturwiss. 1935; 23: 706
- Über Polysaccharidesterschwefelsäuren mit Heparinwirkung. Ztschr. f. physiol. Chem. 1936; 238: 163
- Copley A. L, Robb T. P. Studies on Platelets. II. The Effect of Heparin on the Platelet Count in Vitro. Am. J. Clin. Path. 1942a; 12: 416
- Copley A. L., Robb T. P. Studies on Platelets. III. The effect of Heparin in Vivo on the Platelet Count in Mice and Dogs. Am. J. Clin. Path. 1942b; 12: 563
- Fidlar E., Jaques L. B. The Effect of Commercial Heparin on the Platelet Count. J. Lab. & Clin. Med. 1948; 33: 1410
- Grönwall A., Ingelman B., Mosimann H. A Dextran Sulphuric Acid Ester with Heparin Activity. Uppsala Läkarefören. Förhandl. N. F. 1945; 50: 397
- Halse Th. Fortschritte bei der Behandlung der akuten Thrombose, Thrombophlebitis und Embolic mit Heparin, Dicumarol und Thrombocid. Deutsche Med. Wchnschr. 1949; 74: 1326
- Heparin und Heparinoide. Dicumarol. S. Hirzel, Stuttgart 1950
- Halse Th., Schmitz M. Thrombostatische und Thrombolytische Wirkung eines synthetischen Heparinpräparates. Med. Klin. 1949; 44: 857
- Husemann E. V., Kaulla K. N., Kapesser R. Über blutgerinnungshemmende Substanzen. Ztschr. f. Naturforsch. 1946; 1: 584
- Ingehnan B. An Inulin Sulphuric Acid Ester with Antiocoagulant Activity. Arkiv Kemi, Mineral. Geol. 1946; 24 B(No. 5)
- Kaulla V. K. N., Husemann E. Über Beziehun-gen der Molekülgrösse und -gestalt zur physiologischen Wirkung. Experientia 1946; 2: 223
- Meunier P., Molho D., Moraux J., Cotte J. Apparation du pouvoir anticoagulant au cours de l'esterification sulfurique d'un polysaccharide à effet primitif coagulant, l'alginate de Na. Compt. rend. Soc. de Biol. 1950; 144: 141
- Pantlitschko M., Schmid J., Seelich F., Kaiser E. Über die blutgerinnungshemmende Eigen-schaft sulfurierter Hyaluronsäure. Österreich. Akad. Wissenschaften. Math.-naturwiss. Klasse, Sitzungsberichte, Abt. II b. Chemie 1951; 160: 380
- Piper J. Influence of Synthetic Polysaccharid Sulphuric Acid Esters on the Thrombocytes in vivo and in vitro. Acta physiol. Scandinav. 1945a; 9: 28
- Farmakologiske Undersøgelser over syntetiske koagulationshaemmende Stoffer af Heparin-gruppen. University of Copenhagen. 1945b, Thesis
- The anticoagulant effect of heparin and synthetic polysaccharide-polysulphuric acid esters. Acta Pharmacol, et toxicol. 1946a; 2: 138
- Toxicology of Synthetic Polysaccharide Poly-sulphuric Acid Esters. Acta Pharmacol, et toxicol. 1946b; 2: 317
- The Fate of Heparin in Rabbits after Intravenous Injection. Filtration and Tubular Secretion in the Kidney. Acta Pharmacol, et toxicol. 1947; 3: 373
- Quick A. J., Shanberge J. N., Stefanini M. The Effect of Heparin on Platelets in Vivo. Journ. Lab. & Clin. Med. 1948; 33: 1424
- Ricketts C. R. Chemistry of Dextran and its Derivatives. Proc. Roy. Soc. Med. 1951; 44: 558
- Dextran Sulphate. A Synthetic Analogue of Heparin. Biochem. J. 1952; 51: 129
- Schmid I. Über ein neues Heparinoid. Troisième congrès de la société. Internationale européenne d'hématologie. Rome 1951; 98, Programme
- Schulze W. Zur thrombostatischen Wirkung von Xylanschwefelsáureester. Deutsche Gesund-heitswesen 1950; 5: 1392
- Seifter J., Begany A. J. Studies on the action of a synthetic heparinoid. Am. J. M. Sc. 1948; 216: 234
- Solandt D. Y., Best C. H. Time-Relations of Heparin Action on Blood-Clotting and Platelet Agglutination. Lancet 1940; 238: 1042
- Sorenson C. W., Seifter J., Wright I. S. A new synthetic anticoagulant (heparinoid). Preliminary report of its action in humans. Bull. New York. Acad. Med. 1949; 25: 448
- Sorenson C. W., Wright I. S. Studies with a new synthetic anticoagulant. “Blood clotting and allied problems”, Transactions of the Second Conference, New York, 1949, 221
- Sorenson C. W., Wright I. S. Summary of experiences with the anticoagulant, Paritol (32 cases). “Blood clotting and allied problems”. Transactions of the Third Conference, New York, 1950a, 83
- Sorenson C. W., Wright I. S. A synthetic anticoagulant: A polysulphuric acid ester of polyanhydromannuronic acid (Paritol). Experience with its use in man. Circulation 1950b; 2: 658
- Walton K. Experiments with Dextran Sulphate as an Anticoagulant. Proc. Roy. Soc. Med. 1951; 44: 563
- The Biological Behaviour of a New Synthetic Anticoagulant (Dextran Sulphate) Possessing Heparin-Like Properties. Brit. J. Pharmacol. Chemotherapy. 1952; 7: 370